News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Margaret von Mehren, MD

Articles by Margaret von Mehren, MD

Margaret von Mehren, MD, chief of the Division of Sarcoma Medical Oncology, physician director of the Clinical Trials Office, associate director of Clinical Research, and professor of the Department of Hematology/Oncology at Fox Chase Cancer Center

Dr. von Mehren on Outcomes With Ribociclib/Everolimus in Dedifferentiated Liposarcoma

ByMargaret von Mehren, MD

June 11th 2021

Margaret von Mehren, MD, discusses outcomes with ribociclib and everolimus in dedifferentiated liposarcoma, as seen in the phase 2 SAR-096 trial.

Latest Updated Articles

Trending on OncLive

HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA

Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis

TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg

Dr Eads on Early Data for CDH17-Directed CAR T-Cell Therapy in R/R GI Cancers